They can become virtually any cell in the human body. They can divide indefinitely. And they hold the key to repairing tissues that modern medicine currently can’t fix. Here’s everything you need to know about stem cells — from the basics to the biology that’s changing medicine.
The definition: what makes a cell a stem cell?
Most cells in your body have a fixed identity. A liver cell is a liver cell. A neuron is a neuron. They do their job, they may divide to replace themselves, but they can’t transform into something else. Stem cells are different. They have two unique properties that set them apart from every other cell type in the body.
The first is self-renewal: stem cells can divide and produce more stem cells indefinitely, maintaining a reservoir of undifferentiated cells throughout life. The second is potency: the ability to differentiate — to transform — into one or more specialized cell types. Depending on their origin and type, stem cells can become anything from a heartbeat-generating cardiomyocyte to a dopamine-releasing neuron to an insulin-secreting pancreatic beta cell. They are, in the most literal biological sense, the body’s master builders.
The main types: not all stem cells are equal
Stem cells exist on a spectrum of potency — a hierarchy of how many different cell types they can produce. At the top are totipotent cells: the fertilized egg and its first few divisions, capable of producing every cell in both the embryo and the placenta. Just below are pluripotent stem cells — most famously, embryonic stem cells (ESCs) — which can produce any cell type in the body except the placenta. These are the most versatile, and the most scientifically powerful.
Further down the hierarchy are multipotent stem cells, which can produce multiple but not all cell types — adult bone marrow stem cells, for example, which produce all types of blood cells but not neurons or liver cells. And then unipotent stem cells, which can only produce one cell type — like the muscle satellite cells that repair damaged muscle tissue. Each type has its role, its strengths, and its limitations.
📊 Stem cells by the numbers: The global stem cell therapy and regenerative medicine market reached $28 billion in clinical reality in 2026, according to Boston Biolife. As of late 2024, 115 global clinical trials involving 83 distinct pluripotent stem cell-derived products were registered across ophthalmology, neurology, and oncology — with over 1,200 patients treated and no class-wide safety concerns reported (Kirkeby et al., 2025 / REPROCELL).
Where stem cells live in the adult body
Contrary to what many people assume, stem cells don’t disappear after embryonic development. The adult body maintains reservoirs of stem cells in specific tissues throughout life — called stem cell niches — where they sit in a carefully regulated state of readiness, waiting to be activated by tissue damage or normal cellular turnover.
The best-known adult stem cell reservoir is the bone marrow, which contains hematopoietic stem cells (HSCs) — the source of all blood and immune cells in the body. Every red blood cell, every white blood cell, every platelet you have started as an HSC. Other niches include the gut (which has one of the fastest cell turnover rates in the body, with intestinal stem cells replacing the entire gut lining roughly every five days), the skin, the liver, skeletal muscle, and — more recently confirmed — limited niches in the brain.
The game-changer: induced pluripotent stem cells (iPSCs)
In 2006, Japanese scientist Shinya Yamanaka made a discovery that earned him the Nobel Prize and fundamentally changed the field: he demonstrated that ordinary adult cells — skin cells, blood cells — could be reprogrammed back into a pluripotent state by introducing just four transcription factors, now called the Yamanaka factors (OSKM). These reprogrammed cells became known as induced pluripotent stem cells, or iPSCs.
The implications were staggering. For the first time, scientists could generate pluripotent stem cells from any patient, without embryos, without ethical controversy, and with the patient’s own genetic material — making rejection by the immune system far less likely. iPSCs can be differentiated into virtually any cell type in the lab, creating personalized disease models, drug testing platforms, and therapeutic cell populations that are genetically matched to the individual patient.
🧬 Why iPSCs changed everything: Before iPSCs, pluripotent stem cell research was ethically contentious because it required human embryos. iPSCs bypassed that entirely. They also enabled ‘disease in a dish’ models: taking cells from a patient with Alzheimer’s or Parkinson’s, reprogramming them into iPSCs, and differentiating them into the exact cell types affected by the disease — creating a living, patient-specific model of the disease in the lab.